Parnell Pharmaceuticals Holdings Ltd. (PARNF)
Stock Price: $0.3600 USD
0.0000 (0.00%)
Updated Apr 19, 2021 12:57 PM EDT - Market open
| Market Cap | 2.87M |
| Revenue (ttm) | 28.99M |
| Net Income (ttm) | n/a |
| Shares Out | 18.15M |
| EPS (ttm) | -0.31 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 19 |
| Last Price | $0.3600 |
| Previous Close | $0.3600 |
| Change ($) | 0.0000 |
| Change (%) | 0.00% |
| Day's Open | 0.3600 |
| Day's Range | 0.3600 - 0.3600 |
| Day's Volume | 5,000 |
| 52-Week Range | 0.0500 - 0.5000 |
News
There are no news available yet.
About PARNF
Parnell Pharmaceuticals Holdings Ltd, a veterinary pharmaceutical company, focuses on developing, manufacturing, and commercializing various animal health solutions. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for improving cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical p... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | IPO Date Jun 18, 2014 |
| CEO Robert Joseph | Country Australia |
| Stock Exchange OTCMKTS | Ticker Symbol PARNF |